Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Cheryl T. Lee, MD
University of Michigan Rogel Cancer Center
Study Chair - Chin-Lee Wu, MD, PhD
Massachusetts General Hospital
Study Chair - John J. Coen, MD
GenesisCare USA
Principal Investigator - Philip J. Saylor, MD
Massachusetts General Hospital
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mcgill Cancer Centre at Mcgill University
Montreal, Quebec, Canada
- Georgia Cancer Center for Excellence at Grady Memorial Hospital
Atlanta, Georgia, United States
- Winship Cancer Institute of Emory University
Atlanta, Georgia, United States
- Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
Boise, Idaho, United States
- Cancer Institute at St. John'S Hospital
Springfield, Illinois, United States
- Parkview Regional Cancer Center at Parkview Health
Fort Wayne, Indiana, United States
- St. Agnes Hospital Cancer Center
Baltimore, Maryland, United States
- Hudner Oncology Center at Saint Anne'S Hospital - Fall River
Fall River, Massachusetts, United States
- Saint Joseph Mercy Cancer Center
Ann Arbor, Michigan, United States
- University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States
- West Michigan Cancer Center
Kalamazoo, Michigan, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2008
- Primary completion
- 18 Feb 2018
- Completion
- 20 May 2022
- Last update posted
- 15 Jun 2022
- Registered enrollment
- 70
- Registry id
- NCT00777491
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.